The term KIAA1822L Activators suggests a class of chemical compounds postulated to interact with a protein encoded by a gene that might be designated as KIAA1822L. The KIAA nomenclature originates from a series of genes identified by the Kazusa DNA Research Institute, where many of these genes were initially cataloged without detailed functional information. The protein KIAA1822L would, therefore, require initial investigative research to determine its cellular role, expression patterns, and biochemical properties. If KIAA1822L activators existed, they would be molecules designed to enhance the activity of this protein, which would involve increasing its expression, activity, stability, or modulating its interactions with other cellular components. The design and discovery process of such activators would likely be initiated by high-throughput chemical screening, aiming to identify compounds that can positively modulate the protein's function. Subsequent validation steps would include verifying the specificity of these activators to ensure that the observed effects are due to direct interaction with the KIAA1822L protein.
Developing a deeper understanding of the interaction between KIAA1822L activators and their target protein would involve a series of advanced analytical techniques. Researchers might employ methods such as affinity chromatography to quantify the binding affinity of the activators, or use mass spectrometry to elucidate the molecular weight and structural features of the protein-activator complexes. Additionally, computational tools like molecular dynamics simulations could predict how the activators affect the protein's structure and function. Nuclear magnetic resonance (NMR) spectroscopy could provide insights into the conformational changes within the protein upon activator binding. Through these methods, scientists would seek to map the activator binding sites, understand the mechanism of activation, and characterize the molecular interactions at play. This detailed molecular characterization would be essential for researchers to fully grasp the biochemical implications of activating the KIAA1822L protein, even though, as of now, such a protein and its corresponding activators are purely speculative and not grounded in the current scientific literature.
VEJA TAMBÉM
Items 1 to 10 of 12 total
Mostrar:
| Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Um inibidor da via de sinalização Hh que pode regular positivamente o HHIPL2 como uma resposta compensatória. | ||||||
Purmorphamine | 483367-10-8 | sc-202785 sc-202785A | 1 mg 5 mg | $56.00 $180.00 | 18 | |
Ativa a via Hh e pode potencialmente aumentar a expressão de genes relacionados como o HHIPL2. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Aumenta os níveis de AMPc, o que pode influenciar a expressão dos genes da via Hh, incluindo o HHIPL2. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Pode modular várias vias de desenvolvimento e diferenciação, afectando potencialmente a expressão de HHIPL2. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Um regulador da expressão genética durante o desenvolvimento, pode influenciar a expressão de HHIPL2. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
O lítio pode ativar a sinalização Wnt e pode afetar indiretamente a via Hh e a expressão de HHIPL2. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $26.00 $2754.00 $126.00 $206.00 $572.00 $86.00 | 11 | |
O colesterol é um precursor dos fixadores Hh, e os seus níveis podem influenciar a sinalização da via Hh. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
Um antifúngico que inibe a síntese de esteróis e pode perturbar a sinalização Hh, afectando a expressão de HHIPL2. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Como inibidores da síntese de colesterol, as estatinas podem modular a via Hh e, assim, a expressão de HHIPL2. | ||||||
GANT61 | 500579-04-4 | sc-202630 sc-202630A sc-202630B | 1 mg 5 mg 10 mg | $63.00 $128.00 $200.00 | 6 | |
Um inibidor específico do fator de transcrição de sinalização Hh GLI, que pode alterar a expressão de HHIPL2. | ||||||